Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Does anyone else see this issue between Moore and TPL as a positive?

I agree that RG is trying to develop new revenue streams beyond the MMP for the future. But didn't Moore say he has a new chip design? Wouldn't marketing a new chip also be another revenue stream beyond the MMP and wouldn't that fit nicely into an aquisition or partnership that could blossom into somthing big in the future for PTSC? I know PTSC failed in the past to market the ignite chip but with RG at the helm and Moore's genious and involvement wouldn't potential customers be more motivated to want the new chips?

All the best,

Steve



Share
New Message
Please login to post a reply